Shares of HIMS experienced a dramatic decline today following the unexpected termination of its partnership with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending its stock price plummeting by nearly 20%. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate that it c